PhoenixMD will be joining other breast cancer researchers, physicians and thought leaders at this key event. Keep an eye out for our poster presentation about PMD-026, a first-in-class oral p90 ribosomal S6 kinase (RSK) inhibitor for the treatment of triple negative breast cancer (TNBC).
Back to All Events
Earlier Event: November 3
Susan G. Komen Race for the Cure
Later Event: January 25
Susan G. Komen San Diego’s Metastatic Breast Cancer Conference